Pulmonary

Computerized decision support benefits children on ventilators for lung failure
Patients experienced less time spent on mechanical support and improved recovery.
August 22, 2025
Getty Images 2153665059
Overlooked protein could alter outcome of lung disease
Epac1 has potential as a new drug target for idiopathic pulmonary fibrosis.
August 8, 2025
AM-001 blocks a key protein (Epac1), which helps protect another protein (FoxO3a) from being broken down. It also shuts down several harmful signals that drive lung scarring in idiopathic pulmonary fibrosis, helping to reduce lung damage.
How lymphatic vessels help heal by switching gears
The protein PAR1 triggers a process that clears inflammation and repairs lung damage.
August 7, 2025
Lymphatic vessels (green) are wrapped around blood vessels (red) in a mouse lung. The PAR1 protein triggers lymphatic vessels to be permeable, so they can absorb more fluid and immune cells for healing—a response distinct from blood vessels, where similar changes result in leakage and disease.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
CHEST publishes new guideline on NSCLC management
The evidence-based recommendations will help establish standard of care treatment for patients with early-stage disease.
August 6, 2025
Getty Images 2204506575
Eliminating race from lung function assessments
Physicians, researchers push to update AMA guidelines to improve pulmonary impairment testing process.
August 4, 2025
Getty Images 1420686338
Researchers create 3D-printed living lung tissue
The revolutionary model opens the door to improved understanding of lung disease.
July 29, 2025
Dr. Emmanuel Osei has developed a way to 3D print tissue that resembles a living lung. This work could change how lung disease is studied and improve health options for those living with the illness.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Long COVID’s lasting health concerns
Abnormal PET/MRI findings indicate potential pulmonary and cardiac issues.
July 29, 2025
Getty Images 1392283024
Bronchoscopy performance in diagnostic accuracy, yield
Robotic and electromagnetic navigation bronchoscopy demonstrate similar results to CT-guided biopsy with fewer complications.
July 24, 2025
Getty Images 1500448026
Lung cancer treatment and corticosteroids may not mix
The common medication was found to limit effectiveness of immunotherapies by interfering with T-cell production.
July 22, 2025
Getty Images 1293133630
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Preop fasting and pulmonary aspiration: Is there a link?
Recent study examined the relationship and offered a new recommendation.
July 17, 2025
Getty Images 1992351719
A novel method to detect difficult lung infections
The bacteria-specific diagnostic tool helps locate and monitor M. abscessus pulmonary infections in mouse and human trials.
July 16, 2025
Getty Images 2205851007
Scientists generate lung cells from mouse fibroblasts
The breakthrough may lead to new treatments for serious respiratory diseases.
July 10, 2025
Bright-field and fluorescence images of organoids containing purified iPULs and AT2 cells. Organoids were observed on day 8 in purified iPULs and AT2 cells after the initiation of 3D culture. Scale bar: 1mm (low power) and 100 μm(high power)
Page 1 of 20
Next Page
Most Popular
CHEST publishes new guideline on NSCLC management
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Study points toward potential screening test for COPD
Telehealth, home oxygen therapy could reduce readmissions in COPD patients
Language barriers linked to poorer asthma outcomes
Ethris launches phase 2a clinical trial of mRNA candidate for asthma